The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid Cancer

计划入组 10 人 · 首次发布于 2012 年 12 月 3 日

Impact of CASP3 Gene in Chemoresistance

计划入组 60 人 · 首次发布于 2024 年 1 月 8 日

CASAD for Severe Diarrhea in the Emergency Department

计划入组 2 人 · 首次发布于 2013 年 12 月 23 日

CRISPR-Cas13d(CasRx)

ATXN1 CRISPR/Cas13d gene therapy (Locana bio)

C9orf72 CRISPR/Cas13d gene therapy (amyotrophic lateral sclerosis)

Arbor Biotechnologies Secures $215M Series B to Advance CRISPR Gene Editing Platform

AI-Designed Protein Vehicles Outperform Lipid Nanoparticles for RNA and CRISPR Delivery

FDA Clears HuidaGene's CRISPR-Cas13 RNA-Editing Trial for Macular Degeneration